GSK3739937
- Generic Name
- GSK3739937
A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 21
- Registration Number
- NCT06061081
- Locations
- 🇪🇸
GSK Investigational Site, Vitoria, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath